Topic: Risk, prevention and care in population studies
But when I imagined the short, awkward conversations that would have been likely to ensue, conversations whose power to irk me would almost certainly be out of all proportion to their length, I always made the same swift choice: leave it. Besides, I felt too proud, maybe too safe, to hail them from the impregnable disguise of my transparency. I wasn't alone there in the realm of the invisible; I had company, having often seen the dead walking along Broadway—my mother, for one, who died in 1992, and the poet Rachel Wetzsteon, who took her own life at the end of 2009. I've sometimes seen my husband, who isn't dead, not exactly, striding along. Perhaps I'd caught the condition from my husband, who while he was still living at home, still stalking around the neighborhood and taking daily walks in the park, had become—it's hard to explain, but those versed in dementia will know what I mean—invisible in plain sight.
Key findings
- But when I imagined the short, awkward conversations that would have been likely to ensue, conversations whose power to irk me would almost certainly be out of all proportion to their length, I always made the same swift choice: leave it.
- Besides, I felt too proud, maybe too safe, to hail them from the impregnable disguise of my transparency.
- I wasn't alone there in the realm of the invisible; I had company, having often seen the dead walking along Broadway—my mother, for one, who died in 1992, and the poet Rachel Wetzsteon, who took her own life at the end of 2009.
- I've sometimes seen my husband, who isn't dead, not exactly, striding along.
- Perhaps I'd caught the condition from my husband, who while he was still living at home, still stalking around the neighborhood and taking daily walks in the park, had become—it's hard to explain, but those versed in dementia will know what I mean—invisible in plain sight.
Why it matters
This essay describes the experience of a person whose husband became 'invisible in plain sight' while living with dementia. It contains no findings on treating, curing, or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Evidence strengthLow
How this study scored 21/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 20 of the 97 points we could judge it on, which is 21 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (New England review) |
| Journal's citation record | 0 / 4 | New England review: journal h-index 6 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2011 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 17 year(s) since 2011 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 0 / 4 | Last-listed author Rachel Hadas: h-index 4 (OpenAlex, whole career) |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 20 / 97 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 20 of the 97 points we could judge it on is 21 out of 100. |
| Total | 21 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
APA 7th
Hadas, R. (2011). Invisibility. New England review. https://doi.org/10.1353/ner.2011.a433217
Vancouver
Hadas R. Invisibility. New England review. 2011. doi:10.1353/ner.2011.a433217.
BibTeX
@article{hadas2011-913a79ff,
author = {Hadas, Rachel},
title = {{Invisibility}},
journal = {New England review},
year = {2011},
doi = {10.1353/ner.2011.a433217},
url = {https://doi.org/10.1353/ner.2011.a433217}
}